Also trades as: 3349.T (JPX) · $vol 16M
CSMYF OTC
COSMOS Pharmaceutical Corporation
1W: +9.2%
1M: +9.2%
3M: +9.2%
YTD: -16.2%
1Y: -12.2%
3Y: -16.1%
$40.45
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$596.1B
+13.6% ▲
5Y CAGR: +11.8%
Total Liabilities
$313.1B
+17.1% ▲
5Y CAGR: +12.9%
Shareholders Equity
$284.0B
+10.3% ▲
5Y CAGR: +10.7%
Cash & Investments
$61.4B
+7.6% ▲
5Y CAGR: +2.2%
Total Debt
$78.6B
+57.2% ▲
5Y CAGR: +49.7%
Net Debt
$17.2B
+342.2% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $37.4B | $45.9B | $52.3B | $57.0B | $61.4B |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $37.4B | $45.9B | $52.3B | $57.0B | $61.4B |
| Net Receivables | $10.8B | $12.7B | $12.2B | $12.2B | $20.2B |
| Inventory | $66.4B | $77.5B | $86.2B | $92.3B | $99.1B |
| Other Current Assets | $9.4B | $10.8B | $1.1B | $1.2B | $1.3B |
| Total Current Assets | $115.5B | $137.1B | $154.3B | $165.6B | $185.1B |
| Property, Plant & Equip. | $239.0B | $274.7B | $295.8B | $348.2B | $381.3B |
| Goodwill & Intangibles | $433M | $547M | $497M | $446M | $0 |
| Long-Term Investments | $4.2B | $4.3B | $0 | $0 | $4.7B |
| Other Non-Current Assets | $2.0B | $2.1B | $25.9B | $7.6B | $21.9B |
| Total Non-Current Assets | $247.6B | $283.9B | $322.2B | $359.1B | $411.0B |
| Total Assets | $363.1B | $421.0B | $476.5B | $524.8B | $596.1B |
| — Liabilities — | |||||
| Accounts Payable | $139.2B | $161.9B | $179.5B | $177.1B | $196.0B |
| Short-Term Debt | $1.4B | $2.7B | $4.6B | $5.7B | $11.3B |
| Deferred Revenue | $19.0B | $24.8B | $0 | $0 | $519M |
| Other Current Liabilities | $13.5B | $18.4B | $19.1B | $12.1B | $25.8B |
| Total Current Liabilities | $162.1B | $192.1B | $213.2B | $220.7B | $241.1B |
| Long-Term Debt | $3.0B | $10.0B | $23.4B | $37.2B | $61.9B |
| Other Non-Current Liab. | $4.1B | $4.1B | $4.3B | $4.6B | $4.7B |
| Total Non-Current Liabilities | $10.5B | $17.8B | $31.9B | $46.6B | $72.0B |
| Total Liabilities | $172.5B | $209.9B | $245.1B | $267.3B | $313.1B |
| — Equity — | |||||
| Common Stock | $4.2B | $4.2B | $4.2B | $4.2B | $4.2B |
| Retained Earnings | $182.0B | $202.5B | $222.3B | $248.3B | $274.7B |
| Accumulated OCI | $5M | $40M | $0 | $0 | $235M |
| Total Stockholders Equity | $190.5B | $211.1B | $231.4B | $257.5B | $284.0B |
| Total Liabilities & Equity | $363.1B | $421.0B | $476.5B | $524.8B | $597.1B |
| — Key Metrics — | |||||
| Total Debt | $9.4B | $18.2B | $34.1B | $50.0B | $78.6B |
| Net Debt | -$27.9B | -$27.7B | -$18.2B | -$7.1B | $17.2B |
| Total Investments | $4M | $4M | $0 | $0 | $4.7B |